Form 8-K - Current report:
SEC Accession No. 0001437749-24-037053
Filing Date
2024-12-10
Accepted
2024-12-10 07:10:21
Documents
30
Period of Report
2024-12-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K crvo20241209_8k.htm   iXBRL 8-K 29522
2 EXHIBIT 99.1 ex_755525.htm EX-99.1 19004
3 EXHIBIT 99.2 ex_755526.htm EX-99.2 8759
8 crvo.jpg GRAPHIC 5546
9 slide00.jpg GRAPHIC 48516
10 slide01.jpg GRAPHIC 117096
11 slide02.jpg GRAPHIC 68570
12 slide03.jpg GRAPHIC 77066
13 slide04.jpg GRAPHIC 55216
14 slide05.jpg GRAPHIC 45940
15 slide06.jpg GRAPHIC 55456
16 slide07.jpg GRAPHIC 61611
17 slide08.jpg GRAPHIC 56047
18 slide09.jpg GRAPHIC 75084
19 slide10.jpg GRAPHIC 58732
20 slide11.jpg GRAPHIC 55836
21 slide12.jpg GRAPHIC 48516
  Complete submission text file 0001437749-24-037053.txt   1338985

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA crvo-20241210.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20241210_def.xml EX-101.DEF 11425
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20241210_lab.xml EX-101.LAB 15311
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20241210_pre.xml EX-101.PRE 11585
32 EXTRACTED XBRL INSTANCE DOCUMENT crvo20241209_8k_htm.xml XML 2819
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 241537123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)